ArticleClinical and translational medicine2024
Anlotinib potentiates anti-PD1 immunotherapy via transferrin receptor-dependent CD8
Fei Song et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
46 papers cite it
this paperpooled ittrialcites it